BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37699386)

  • 1. Slowing of Peripheral Nerve Conduction Velocity in Children and Adolescents With Type 1 Diabetes Is Predicted by Glucose Fluctuations.
    Oberhauser SS; l'Allemand D; Willems EP; Gozzi T; Heldt K; Eilers M; Stasinaki A; Lütschg J; Broser PJ
    Diabetes; 2023 Dec; 72(12):1835-1840. PubMed ID: 37699386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological Characterization of Neuropathy Complicating Type 1 Diabetes Mellitus.
    Abuelwafaa N; Ahmed H; Omer I; Abdullah M; Ahmed A; Musa A
    J Diabetes Res; 2019; 2019():2435261. PubMed ID: 31355291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of peripheral neuropathy and associated risk factors in children with type 1 diabetes.
    Singh I; Reddy C; Saini AG; Dayal D; Sharawat IK; Kasinathan A; Sachdeva N; Attri S; Sankhyan N
    Prim Care Diabetes; 2022 Apr; 16(2):287-292. PubMed ID: 34998692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical nerve dysfunction in children and adolescents with IDDM.
    Hyllienmark L; Brismar T; Ludvigsson J
    Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy in diabetic children and adolescents. A cross-sectional study.
    Käär ML; Saukkonen AL; Pitkänen M; Akerblom HK
    Acta Paediatr Scand; 1983 May; 72(3):373-8. PubMed ID: 6603739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Femoral versus peroneal neuropathy in diabetic children and adolescents--relationships to clinical status, metabolic control and retinopathy.
    Kruger M; Brunko E; Dorchy H; Noël P
    Diabete Metab; 1987 Apr; 13(2):110-5. PubMed ID: 3595967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of peripheral neuropathy with insulin-dependent diabetes mellitus.
    Bao XH; Wong V; Wang Q; Low LC
    Pediatr Neurol; 1999 Mar; 20(3):204-9. PubMed ID: 10207929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of TNF-α in peripheral neuropathy patients and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2013; 7(4):238-42. PubMed ID: 24290092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.
    Schamarek I; Herder C; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
    Eur J Endocrinol; 2016 Apr; 174(4):433-43. PubMed ID: 26733478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation analysis between plasma fibrinogen and nerve electrophysiological changes in type 2 diabetic peripheral neuropathy.
    Gu W; Li Z; Zhu X; Huang X; Zhang D; Jiang Y; Ye Z; Sun Y; Ao P; Zhang X; Cao Q; Wei L; Wang S
    Folia Neuropathol; 2023; 61(2):153-162. PubMed ID: 37587890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin.
    Graf RJ; Halter JB; Halar E; Porte D
    Ann Intern Med; 1979 Mar; 90(3):298-303. PubMed ID: 426398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of subclinical neuropathy in diabetic patients: assessment by study of conduction velocity distribution within motor and sensory nerve fibres.
    Bertora P; Valla P; Dezuanni E; Osio M; Mantica D; Bevilacqua M; Norbiato G; Caccia MR; Mangoni A
    J Neurol; 1998 Feb; 245(2):81-6. PubMed ID: 9507412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: Relation to nerve conduction studies.
    Elbarbary NS; Ismail EAR; El-Hilaly RA; Ahmed FS
    Int Immunopharmacol; 2018 Jun; 59():68-75. PubMed ID: 29627577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic pattern and prevalence of subclinical peripheral neuropathy in children and adolescents with type I diabetes mellitus in Iran.
    Toopchizadeh V; Shiva S; Khiabani NY; Ghergherechi R
    Saudi Med J; 2016 Mar; 37(3):299-303. PubMed ID: 26905353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aerobic training on nerve conduction in men with type 2 diabetes and peripheral neuropathy: A randomized controlled trial.
    Gholami F; Nikookheslat S; Salekzamani Y; Boule N; Jafari A
    Neurophysiol Clin; 2018 Sep; 48(4):195-202. PubMed ID: 29606547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the clinical efficacy of multiple lower-extremity nerve decompression in diabetic peripheral neuropathy.
    Zhang W; Zhong W; Yang M; Shi J; Guowei L; Ma Q
    Br J Neurosurg; 2013 Dec; 27(6):795-9. PubMed ID: 23713665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral nerve function is increasingly impaired during puberty in adolescents with type 1 diabetes.
    Riihimaa PH; Suominen K; Tolonen U; Jäntti V; Knip M; Tapanainen P
    Diabetes Care; 2001 Jun; 24(6):1087-92. PubMed ID: 11375375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of TGF-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S135-9. PubMed ID: 26559756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study.
    Charles M; Soedamah-Muthu SS; Tesfaye S; Fuller JH; Arezzo JC; Chaturvedi N; Witte DR;
    Diabetes Care; 2010 Dec; 33(12):2648-53. PubMed ID: 20823346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.